Polyneuropathy and vasculitis associated with IgG type I Cryoglobulinemia can be treated effectively with the anti-CD20 monoclonal antibody (Rituximab).

被引：0
|
作者：
Rosenthal, E [1 ]
Pesce, A [1 ]
Karsenti, JM [1 ]
Allieri-Rosenthal, MA [1 ]
Cassuto, JP [1 ]
机构：
[1] Archet 1 Hosp, Nice, France
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4914
引用
收藏
页码：292B / 292B
页数：1
相关论文
共 50 条
  • [21] Rituximab (anti-CD20 monoclonal antibody) - Ultimate or first choice in pemphigus?
    Hertl, Michael
    Eming, Ruediger
    Borradori, Luca
    DERMATOLOGY, 2007, 214 (04) : 275 - 277
  • [22] An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
    Boye, J
    Elter, T
    Engert, A
    ANNALS OF ONCOLOGY, 2003, 14 (04) : 520 - 535
  • [23] Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)
    Dupuy, A
    Viguier, M
    Bédane, C
    Cordoliani, F
    Blaise, S
    Aucouturier, F
    Bonnetblanc, JM
    Morel, P
    Dubertret, L
    Bachelez, H
    ARCHIVES OF DERMATOLOGY, 2004, 140 (01) : 91 - 96
  • [24] Treatment of Cutaneous Lymphoid Hyperplasia with the Monoclonal Anti-CD20 Antibody Rituximab
    Martin, Stephanie J.
    Duvic, Madeleine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (03): : 286 - 288
  • [25] Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)
    Heiligenhaus, Arnd
    Miserocchi, Elisabetta
    Heinz, Carsten
    Gerloni, Valeria
    Kotaniemi, Kaisu
    RHEUMATOLOGY, 2011, 50 (08) : 1390 - 1394
  • [26] Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab:: an open study
    Salvi, Mario
    Vannucchi, Guia
    Campi, Irene
    Curro, Nicola
    Dazzi, Davide
    Simonetta, Simona
    Bonara, Paola
    Rossi, Stefania
    Sina, Clara
    Guastella, Claudio
    Ratiglia, Roberto
    Beck-Peccoz, Paolo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (01) : 33 - 40
  • [27] Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab)
    Arzoo, K
    Sadeghi, S
    Liebman, HA
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) : 922 - 924
  • [28] Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the Anti-CD20 monoclonal antibody rituximab
    Wallet-Faber, N.
    Franck, N.
    Batteux, F.
    Mateus, C.
    Gilbert, D.
    Carlotti, A.
    Avril, M. F.
    Dupin, N.
    DERMATOLOGY, 2007, 215 (03) : 252 - 255
  • [29] Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris
    Faurschou, Annesofie
    Gniadecki, Robert
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (03) : 292 - 294
  • [30] Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
    Bhatia, A
    Ell, PJ
    Edwards, JCW
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1099 - 1100
12345